Human Papillomavirus type distribution in invasive cervical cancer in Uganda

被引：31

作者：

Odida M. ^{[1
,2
]}

de Sanjosé S. ^{[3
]}

Quint W. ^{[4
]}

Bosch X.F. ^{[3
]}

Klaustermeier J. ^{[3
]}

Weiderpass E. ^{[2
,5
,6
,7
]}

机构：

[1] Department of Pathology, Faculty of Medicine, Makerere University, Kampala

[2] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm

[3] Unit of Infections and Cancer, Catalan Institute of Oncology, Barcelona

[4] DDL Diagnostic Laboratory, Voorburg

[5] Department of Etiological Research, The Cancer Registry of Norway, Oslo

[6] Department of Genetic Epidemiology, Samfunded Folkhalsan, Helsinki

[7] Department of Community Medicine, Tromso University, Tromso

来源：

BMC Infectious Diseases | / 8卷 / 1期

关键词：

Cervical Cancer; Invasive Cervical Cancer; Multiple Infection; Cervical Cancer Case; Invasive Cervical Carcinoma;

D O I：

10.1186/1471-2334-8-85

中图分类号：

学科分类号：

摘要：

Background: We conducted a study aiming to describe Human Papillomavirus (HPV) type distribution in invasive cervical carcinoma in Uganda. Methods: 191 archival cervical carcinoma samples diagnosed in the Department of Pathology, Makerere University in Kampala between 1968 and 1992 were analysed using a sensitive PCR-Reverse Hybridization Line Probe Assay. Results: Out of the 186 cases of confirmed invasive cervical cancer in the study paraffin blocks, 114 were positive for HPV DNA. Specific HPV genotypes were identifiable in 109 cases: HPV 16, 18, 31, 35, 39, 44, 45, 51, 52 and 70. These occurred as single infections in 105 cases (96.3%) and as multiple infections in 4 cases (3.7%). HPV 16 or 18 accounted for 80% (84/105) of cases with single infection. Conclusion: The results of this study confirm the role of HPV 16 and 18 in cervical cancer pathogenesis in the Ugandan population. The results suggest that the currently available HPV vaccines against HPV 16 and 18 could possibly prevent the majority of invasive cervical cancers in Uganda. © 2008 Odida et al; licensee BioMed Central Ltd.

引用

共 36 条

[1]

Castellsague X., Diaz M., de Sanjose S., Munoz N., Herrero R., Franceschi S., Peeling R.W., Ashley R., Smith J.S., Snijders P.J., Meijer C.J., Bosch F.X., Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention, J Natl Cancer Inst, 98, pp. 303-315, (2006)

[2]

Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, pp. 12-19, (1999)

[3]

zur Hausen H., Papillomavirus infections - A major cause of human cancers, Biochim Biophys Acta, 1288, (1996)

[4]

Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., Shah K.V., Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group, J Natl Cancer Inst, 87, pp. 796-802, (1995)

[5]

Munoz N., Bosch F.X., de Sanjose S., Tafur L., Izarzugaza I., Gili M., Viladiu P., Navarro C., Martos C., Ascunce N., The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain, Int J Cancer, 52, pp. 743-749, (1992)

[6]

Chichareon S., Herrero R., Munoz N., Bosch F.X., Jacobs M.V., Deacon J., Santamaria M., Chongsuvivatwong V., Meijer C.J., Walboomers J.M., Risk factors for cervical cancer in Thailand: A case-control study, J Natl Cancer Inst, 90, pp. 50-57, (1998)

[7]

Tase T., Sato S., Wada Y., Yajima A., Okagaki T., Prevalence of human papillomavirus type 18 DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix occurring in Japan, Tohoku J Exp Med, 156, pp. 47-53, (1988)

[8]

Wilczynski S.P., Bergen S., Walker J., Liao S.Y., Pearlman L.F., Human papillomaviruses and cervical cancer: Analysis of histopathologic features associated with different viral types, Hum Pathol, 19, pp. 697-704, (1988)

[9]

Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., Clifford G.M., Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update, Int J Cancer, 121, pp. 621-632, (2007)

[10]

Clifford G.M., Smith J.S., Plummer M., Munoz N., Franceschi S., Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis, Br J Cancer, 88, pp. 63-73, (2003)

← 1 2 3 4 →